|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in increased expression of AKT1 protein] |
CTD |
PMID:34605098 |
|
NCBI chr12:112,620,255...112,641,318
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in increased expression of BAX protein] |
CTD |
PMID:34605098 |
|
NCBI chr 7:45,111,119...45,116,344
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] |
CTD |
PMID:34605098 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] |
CTD |
PMID:34605098 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; corilagin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:30582900 PMID:34605098 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in increased activity of HMGCR protein] |
CTD |
PMID:34605098 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in increased expression of IL6 protein] |
CTD |
PMID:34605098 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
corilagin inhibits the reaction [1-naphthyl isothiocyanate decreases expression of nr1h4 mRNA and protein in rat liver]; corilagin increases expression of nr1h4 mRNA and protein in rat embryonic liver cells |
RGD |
PMID:29235094 |
RGD:15042872 |
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
corilagin inhibits the reaction [Doxorubicin results in increased expression of PPARG protein] |
CTD |
PMID:34605098 |
|
NCBI chr 6:115,337,840...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion multiple interactions |
EXP ISO |
corilagin results in decreased secretion of TNF protein corilagin inhibits the reaction [Doxorubicin results in increased expression of TNF protein] |
CTD |
PMID:12628509 PMID:34605098 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] |
CTD |
PMID:32971123 |
|
NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
|
|
G |
Acpp |
acid phosphatase, prostate |
increases expression |
ISO |
Ellagic Acid results in increased expression of ACP3 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 9:104,165,439...104,214,921
Ensembl chr 9:104,165,450...104,214,947
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
increases expression |
ISO |
Ellagic Acid results in increased expression of AIFM1 protein |
CTD |
PMID:23554011 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
increases phosphorylation |
ISO |
Ellagic Acid results in increased phosphorylation of AKT1 protein |
CTD |
PMID:26986492 |
|
NCBI chr12:112,620,255...112,641,318
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
multiple interactions affects binding |
ISO |
ALB protein promotes the reaction [Ellagic Acid results in increased activity of F12 protein] Ellagic Acid binds to ALB protein |
CTD |
PMID:6343536 PMID:25247703 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Alkbh2 |
alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase |
decreases activity |
ISO |
Ellagic Acid results in decreased activity of ALKBH2 protein |
CTD |
PMID:31088072 |
|
NCBI chr 5:114,261,987...114,269,293
Ensembl chr 5:114,261,987...114,266,279
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
decreases expression increases expression |
ISO |
Ellagic Acid results in decreased expression of APAF1 mRNA Ellagic Acid results in increased expression of APAF1 mRNA |
CTD |
PMID:12002526 PMID:35179410 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
increases expression |
ISO |
Ellagic Acid results in increased expression of ASCL1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr10:87,326,681...87,329,522
Ensembl chr10:87,326,681...87,329,522
|
|
G |
Asns |
asparagine synthetase |
increases expression |
ISO |
Ellagic Acid results in increased expression of ASNS mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 6:7,675,165...7,693,209
Ensembl chr 6:7,675,169...7,693,254
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Ellagic Acid results in increased expression of ATF3 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Ellagic Acid results in increased expression of ATG5 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
ISO |
Ellagic Acid results in increased expression of BAD protein |
CTD |
PMID:23554011 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
ISO |
Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of BAX mRNA] Ellagic Acid results in increased expression of BAX mRNA |
CTD |
PMID:29854611 PMID:35179410 |
|
NCBI chr 7:45,111,119...45,116,344
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
increases expression decreases expression multiple interactions |
ISO EXP |
Ellagic Acid results in increased expression of BCL2 protein Ellagic Acid results in decreased expression of BCL2 mRNA Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA] [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA] |
CTD |
PMID:20103723 PMID:22386815 PMID:29854611 PMID:35179410 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of BMP6 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr13:38,529,692...38,684,290
Ensembl chr13:38,529,083...38,684,278
|
|
G |
Brf1 |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of BRF1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr12:112,919,251...112,964,327
Ensembl chr12:112,923,705...112,964,324
|
|
G |
Calr |
calreticulin |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of CALR mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity decreases activity decreases expression |
ISO |
Ellagic Acid results in increased expression of CASP3 mRNA Ellagic Acid inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased activity of CASP3 protein] Ellagic Acid results in increased expression of and results in increased activity of CASP3 protein Ellagic Acid results in increased activity of CASP3 protein Ellagic Acid results in decreased activity of CASP3 protein Ellagic Acid results in decreased expression of CASP3 mRNA |
CTD |
PMID:12002526 PMID:22386815 PMID:23554011 PMID:23811531 PMID:28815802 PMID:29854611 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Ellagic Acid results in increased expression of and results in increased activity of CASP9 protein |
CTD |
PMID:23554011 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
ISO |
Ellagic Acid results in increased activity of CAT protein Ellagic Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of CAT protein]; Ellagic Acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] |
CTD |
PMID:20074268 PMID:24877639 PMID:29864931 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
decreases secretion |
ISO |
Ellagic Acid results in decreased secretion of CCL2 protein |
CTD |
PMID:20816778 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccng1 |
cyclin G1 |
decreases expression |
ISO |
ellagic acid inhibits the reaction [estrogen increases expression of Ccng1 mRNA and protein in rat mammary tissue] |
RGD |
PMID:23791885 |
RGD:151356928 |
NCBI chr11:40,639,379...40,646,155
Ensembl chr11:40,639,379...40,646,138
|
|
G |
Cd14 |
CD14 antigen |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of CD14 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of CDK1 protein |
CTD |
PMID:23554011 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
multiple interactions increases expression |
EXP ISO |
[resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA] [Ellagic Acid co-treated with Quercetin] results in increased expression of CDKN1A mRNA; Ellagic Acid promotes the reaction [Quercetin results in increased expression of CDKN1A protein]; pifithrin inhibits the reaction [Ellagic Acid promotes the reaction [Quercetin results in increased expression of CDKN1A protein]] Ellagic Acid results in increased expression of CDKN1A protein |
CTD |
PMID:15735102 PMID:20103723 PMID:23554011 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] |
CTD |
PMID:21762681 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein] |
CTD |
PMID:32971123 |
|
NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
|
|
G |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
multiple interactions decreases expression |
ISO |
Ellagic Acid inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] Ellagic Acid results in decreased expression of CXCL8 mRNA |
CTD |
PMID:18377686 PMID:35179410 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression decreases activity |
ISO EXP |
Ellagic Acid results in decreased expression of CYP1A1 mRNA Ellagic Acid results in decreased activity of CYP1A1 protein |
CTD |
PMID:19329757 PMID:20816778 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity multiple interactions |
EXP |
Ellagic Acid results in decreased activity of CYP1B1 protein [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:19329757 PMID:20103723 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Daxx |
Fas death domain-associated protein |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of DAXX mRNA |
CTD |
PMID:12002526 |
|
NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564
|
|
G |
Dffa |
DNA fragmentation factor, alpha subunit |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of DFFA mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 4:149,188,599...149,205,110
Ensembl chr 4:149,188,603...149,205,104
|
|
G |
E4f1 |
E4F transcription factor 1 |
increases expression |
ISO |
Ellagic Acid results in increased expression of E4F1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr17:24,662,752...24,674,366
Ensembl chr17:24,662,752...24,689,287
|
|
G |
Egr3 |
early growth response 3 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of EGR3 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr14:70,314,766...70,320,062
Ensembl chr14:70,314,652...70,320,063
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
Ellagic Acid results in increased expression of ENDOG protein |
CTD |
PMID:23554011 |
|
NCBI chr 2:30,061,421...30,064,081
Ensembl chr 2:30,061,505...30,064,081
|
|
G |
Ep300 |
E1A binding protein p300 |
increases expression |
ISO |
Ellagic Acid results in increased expression of EP300 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr15:81,470,329...81,536,278
Ensembl chr15:81,469,552...81,536,278
|
|
G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
increases expression |
ISO |
Ellagic Acid results in increased expression of EPS15 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 4:109,137,372...109,245,014
Ensembl chr 4:109,137,465...109,245,014
|
|
G |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
increases expression |
ISO |
Ellagic Acid results in increased expression of EZH1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr11:101,081,941...101,117,289
Ensembl chr11:101,081,941...101,117,289
|
|
G |
F12 |
coagulation factor XII (Hageman factor) |
multiple interactions increases activity |
ISO |
ALB protein promotes the reaction [Ellagic Acid results in increased activity of F12 protein] |
CTD |
PMID:6343536 |
|
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of FGFR1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 8:26,008,775...26,065,734
Ensembl chr 8:26,003,670...26,065,734
|
|
G |
Flna |
filamin, alpha |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of FLNA mRNA |
CTD |
PMID:12002526 |
|
NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of FN1 protein] |
CTD |
PMID:24877639 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
EXP |
[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein] |
CTD |
PMID:20103723 PMID:32971123 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
decreases activity |
ISO |
Ellagic Acid results in decreased activity of G6PD protein |
CTD |
PMID:25130191 |
|
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
|
|
G |
Gal |
galanin and GMAP prepropeptide |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [phosalone results in increased activity of GAL protein] |
CTD |
PMID:27965107 |
|
NCBI chr19:3,459,915...3,464,544
Ensembl chr19:3,459,915...3,464,544
|
|
G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of GPLD1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr13:25,127,135...25,175,919
Ensembl chr13:25,127,135...25,176,484
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of GPT protein]; Ellagic Acid inhibits the reaction [sodium arsenite results in increased expression of GPT protein] |
CTD |
PMID:24877639 PMID:29935397 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mRNA] |
CTD |
PMID:29935397 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gsr |
glutathione reductase |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of GSR protein] |
CTD |
PMID:24877639 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
affects expression |
ISO |
Ellagic Acid affects the expression of GSTT1 protein |
CTD |
PMID:9855024 |
|
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Gtf2e2 |
general transcription factor II E, polypeptide 2 (beta subunit) |
increases expression |
ISO |
Ellagic Acid results in increased expression of GTF2E2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 8:34,221,942...34,267,201
Ensembl chr 8:34,221,861...34,267,201
|
|
G |
Gtf2h4 |
general transcription factor II H, polypeptide 4 |
increases expression |
ISO |
Ellagic Acid results in increased expression of GTF2H4 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr17:35,978,620...35,984,641
Ensembl chr17:35,978,622...35,984,631
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of GUSB protein] |
CTD |
PMID:21762681 |
|
NCBI chr 5:130,011,278...130,031,890
Ensembl chr 5:130,017,852...130,031,890
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of HIF1A mRNA |
CTD |
PMID:12002526 |
|
NCBI chr12:73,948,098...73,994,328
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hlcs |
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
decreases activity |
ISO |
Ellagic Acid results in decreased activity of HLCS protein |
CTD |
PMID:26303405 |
|
NCBI chr16:93,930,054...94,116,098
Ensembl chr16:93,929,741...94,114,430
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
Ellagic Acid results in increased expression of HMOX1 mRNA; Ellagic Acid results in increased expression of HMOX1 protein [Paraquat co-treated with Ellagic Acid] results in increased expression of HMOX1 mRNA; [Paraquat co-treated with Ellagic Acid] results in increased expression of HMOX1 protein |
CTD |
PMID:22386815 PMID:23546295 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hras |
Harvey rat sarcoma virus oncogene |
multiple interactions |
EXP |
[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene] |
CTD |
PMID:20103723 |
|
NCBI chr 7:140,769,847...140,773,938
Ensembl chr 7:140,769,018...140,773,918
|
|
G |
Ier2 |
immediate early response 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of IER2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 8:85,387,960...85,389,481
Ensembl chr 8:85,387,960...85,389,483
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of IFNG mRNA]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of IFNG protein] |
CTD |
PMID:29854611 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of IGFBP2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 1:72,863,639...72,891,633
Ensembl chr 1:72,863,662...72,891,633
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of IGFBP4 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr11:98,930,820...98,943,481
Ensembl chr11:98,932,070...98,945,218
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression multiple interactions |
ISO |
Ellagic Acid results in decreased expression of IL1B mRNA Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of IL1B mRNA]; Ellagic Acid inhibits the reaction [sodium arsenite results in increased expression of IL1B protein] Ellagic Acid inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] |
CTD |
PMID:18377686 PMID:20816778 PMID:21762681 PMID:24877639 PMID:27965107 PMID:29455002 PMID:29854611 PMID:29864931 More...
|
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1r1 |
interleukin 1 receptor, type I |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of IL1R1 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of IL6 protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL6 protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of IL6 mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of IL6 protein] |
CTD |
PMID:21762681 PMID:24877639 PMID:27965107 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
increases expression |
ISO |
Ellagic Acid results in increased expression of INPP5D mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 1:87,548,034...87,648,232
Ensembl chr 1:87,548,034...87,648,229
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of IQGAP2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr13:95,763,685...96,028,788
Ensembl chr13:95,763,682...96,028,991
|
|
G |
Irf9 |
interferon regulatory factor 9 |
increases expression |
ISO |
Ellagic Acid results in increased expression of IRF9 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr14:55,841,442...55,847,487
Ensembl chr14:55,841,028...55,847,487
|
|
G |
Jun |
jun proto-oncogene |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of JUN mRNA; Ellagic Acid results in decreased expression of JUN protein modified form |
CTD |
PMID:23811531 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Litaf |
LPS-induced TN factor |
increases expression |
ISO |
Ellagic Acid results in increased expression of LITAF mRNA |
CTD |
PMID:12002526 |
|
NCBI chr16:10,777,137...10,810,985
Ensembl chr16:10,777,139...10,884,021
|
|
G |
Map1a |
microtubule-associated protein 1 A |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of MAP1A mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 2:121,119,608...121,141,313
Ensembl chr 2:121,120,081...121,141,313
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of MAP3K1 mRNA; Ellagic Acid results in decreased expression of MAP3K1 protein |
CTD |
PMID:23811531 |
|
NCBI chr13:111,882,962...111,954,803
Ensembl chr13:111,882,962...111,945,527
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:32971123 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk11 |
mitogen-activated protein kinase 11 |
increases expression |
ISO |
Ellagic Acid results in increased expression of MAPK11 mRNA |
CTD |
PMID:23811531 |
|
NCBI chr15:89,026,685...89,033,809
Ensembl chr15:89,026,689...89,033,831
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [phosalone results in increased expression of MAPK14 protein] |
CTD |
PMID:27965107 |
|
NCBI chr17:28,910,243...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:32971123 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
[Ellagic Acid co-treated with Quercetin] results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:15735102 |
|
NCBI chr14:33,099,855...33,169,215
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
[Ellagic Acid co-treated with Quercetin] results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:15735102 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
decreases activity |
ISO |
Ellagic Acid results in decreased activity of MGST1 protein |
CTD |
PMID:16125204 |
|
NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753
|
|
G |
Mmd |
monocyte to macrophage differentiation-associated |
increases expression |
ISO |
Ellagic Acid results in increased expression of MMD mRNA |
CTD |
PMID:12002526 |
|
NCBI chr11:90,140,102...90,169,399
Ensembl chr11:90,140,282...90,169,415
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases activity decreases expression |
ISO |
Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein; zinc chloride inhibits the reaction [Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein] Ellagic Acid results in decreased activity of MMP2 protein Ellagic Acid results in decreased expression of MMP2 mRNA |
CTD |
PMID:21573219 PMID:35179410 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression decreases activity |
ISO |
Ellagic Acid results in decreased expression of MMP9 mRNA Ellagic Acid results in decreased activity of MMP9 protein |
CTD |
PMID:35179410 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
multiple interactions |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] |
CTD |
PMID:32971123 |
|
NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
affects localization multiple interactions increases expression affects response to substance |
ISO EXP |
Ellagic Acid affects the localization of NFE2L2 protein Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] Ellagic Acid results in increased expression of NFE2L2 mRNA [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein; [Paraquat co-treated with Ellagic Acid] results in increased expression of NFE2L2 mRNA; Ellagic Acid results in increased expression of and affects the localization of NFE2L2 protein Ellagic Acid results in increased expression of NFE2L2 mRNA; Ellagic Acid results in increased expression of NFE2L2 protein NFE2L2 protein affects the susceptibility to Ellagic Acid |
CTD |
PMID:22386815 PMID:23546295 PMID:30503583 |
|
NCBI chr 2:75,505,857...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of NFKB2 mRNA |
CTD |
PMID:12002526 PMID:35179410 |
|
NCBI chr19:46,285,478...46,300,839
Ensembl chr19:46,292,759...46,300,824
|
|
G |
Nnat |
neuronatin |
increases expression |
ISO |
Ellagic Acid results in increased expression of NNAT mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 2:157,401,936...157,404,445
Ensembl chr 2:157,401,998...157,404,442
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of NOP56 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 2:130,112,904...130,121,233
Ensembl chr 2:130,116,350...130,121,233
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions decreases expression |
ISO |
Ellagic Acid inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] Ellagic Acid results in decreased expression of NOS2 mRNA |
CTD |
PMID:28815802 PMID:35179410 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of NPAS2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression multiple interactions |
ISO |
Ellagic Acid results in increased expression of NQO1 mRNA; Ellagic Acid results in increased expression of NQO1 protein [Paraquat co-treated with Ellagic Acid] results in increased expression of NQO1 mRNA; [Paraquat co-treated with Ellagic Acid] results in increased expression of NQO1 protein |
CTD |
PMID:23546295 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO EXP |
Ellagic Acid results in increased activity of NR1I3 protein |
CTD |
PMID:21821919 |
|
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
decreases activity |
ISO |
Ellagic Acid results in decreased activity of PARG protein |
CTD |
PMID:19840838 |
|
NCBI chr14:31,923,900...32,020,671
Ensembl chr14:31,923,906...32,019,507
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] |
CTD |
PMID:25247703 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA] |
CTD |
PMID:20103723 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Pdia2 |
protein disulfide isomerase associated 2 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein] |
CTD |
PMID:25247703 |
|
NCBI chr17:26,414,973...26,418,108
Ensembl chr17:26,414,973...26,418,061
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases activity |
ISO |
Ellagic Acid results in decreased activity of PGD protein |
CTD |
PMID:25130191 |
|
NCBI chr 4:149,234,448...149,251,162
Ensembl chr 4:149,234,448...149,251,228
|
|
G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of PLA2G2A mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497
|
|
G |
Plp2 |
proteolipid protein 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of PLP2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr X:7,534,180...7,537,629
Ensembl chr X:7,534,180...7,537,629
|
|
G |
Pml |
promyelocytic leukemia |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of PML mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 9:58,124,462...58,157,077
Ensembl chr 9:58,125,359...58,157,069
|
|
G |
Ppard |
peroxisome proliferator activator receptor delta |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of PPARD mRNA |
CTD |
PMID:12002526 |
|
NCBI chr17:28,451,657...28,520,446
Ensembl chr17:28,451,674...28,520,448
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
increases expression |
ISO |
Ellagic Acid results in increased expression of PPARG protein |
CTD |
PMID:23811531 |
|
NCBI chr 6:115,337,840...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
multiple interactions decreases expression |
EXP |
Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of PPARGC1A mRNA] Ellagic Acid results in decreased expression of PPARGC1A mRNA |
CTD |
PMID:30503583 |
|
NCBI chr 5:51,611,591...52,273,337
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Prkg1 |
protein kinase, cGMP-dependent, type I |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of PRKG1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr19:30,541,887...31,742,667
Ensembl chr19:30,541,889...31,742,433
|
|
G |
Ptn |
pleiotrophin |
decreases expression increases expression |
ISO |
Ellagic Acid results in decreased expression of PTN mRNA Ellagic Acid results in increased expression of PTN mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 6:36,691,859...36,787,114
Ensembl chr 6:36,691,864...36,787,155
|
|
G |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of PTPRN2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr12:116,449,316...117,241,787
Ensembl chr12:116,449,340...117,240,469
|
|
G |
Ran |
RAN, member RAS oncogene family |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of RAN mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 5:129,097,220...129,101,386
Ensembl chr 5:129,097,133...129,101,387
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [phosalone results in increased expression of RB1 mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of RB1 protein] |
CTD |
PMID:27965107 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
increases expression multiple interactions |
ISO |
Ellagic Acid results in increased expression of RECK mRNA; Ellagic Acid results in increased expression of RECK protein zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA]; zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein] |
CTD |
PMID:21573219 |
|
NCBI chr 4:43,875,521...43,944,806
Ensembl chr 4:43,875,530...43,944,806
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
decreases expression multiple interactions |
ISO EXP |
Ellagic Acid results in decreased expression of RELA mRNA Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of RELA protein] Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of RELA protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of RELA protein]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of RELA protein] |
CTD |
PMID:12002526 PMID:24877639 PMID:27965107 PMID:32971123 |
|
NCBI chr19:5,687,569...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rgs5 |
regulator of G-protein signaling 5 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of RGS5 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 1:169,483,070...169,523,382
Ensembl chr 1:169,483,070...169,523,382
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of SCD mRNA |
CTD |
PMID:20816778 |
|
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
|
|
G |
Septin2 |
septin 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of SEPTIN2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 1:93,406,671...93,437,455
Ensembl chr 1:93,406,686...93,437,982 Ensembl chr 1:93,406,686...93,437,982
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] |
CTD |
PMID:29935397 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of SOD3 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
|
|
G |
Src |
Rous sarcoma oncogene |
multiple interactions |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC protein] |
CTD |
PMID:32971123 |
|
NCBI chr 2:157,265,790...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Star |
steroidogenic acute regulatory protein |
increases expression multiple interactions |
EXP |
Ellagic Acid results in increased expression of STAR mRNA Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of STAR mRNA] |
CTD |
PMID:30503583 |
|
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression decreases expression |
ISO |
Ellagic Acid results in increased expression of STAT3 mRNA Ellagic Acid results in decreased expression of STAT3 mRNA |
CTD |
PMID:12002526 PMID:20816778 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Taf1c |
TATA-box binding protein associated factor, RNA polymerase I, C |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of TAF1C mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 8:120,324,713...120,331,945
Ensembl chr 8:120,324,610...120,331,961
|
|
G |
Tcf12 |
transcription factor 12 |
increases expression |
ISO |
Ellagic Acid results in increased expression of TCF12 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 9:71,751,534...72,019,611
Ensembl chr 9:71,749,970...72,019,153
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions increases expression |
ISO |
Ellagic Acid inhibits the reaction [Estradiol results in increased expression of TERT mRNA alternative form] Ellagic Acid inhibits the reaction [phosalone results in decreased activity of TERT protein] Ellagic Acid results in increased expression of TERT mRNA alternative form |
CTD |
PMID:19501078 PMID:27965107 |
|
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tfam |
transcription factor A, mitochondrial |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of TFAM mRNA |
CTD |
PMID:12002526 |
|
NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression multiple interactions |
ISO |
Ellagic Acid results in increased expression of TGFB1 mRNA Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TGFB1 protein] |
CTD |
PMID:12002526 PMID:24877639 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein] Ellagic Acid results in decreased expression of TNF mRNA |
CTD |
PMID:21762681 PMID:24877639 PMID:27965107 PMID:28815802 PMID:29455002 PMID:29854611 PMID:29864931 PMID:35179410 More...
|
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
multiple interactions affects binding |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein binds to TNFRSF11A protein] Ellagic Acid binds to TNFRSF11A protein |
CTD |
PMID:32971123 |
|
NCBI chr 1:105,708,448...105,777,172
Ensembl chr 1:105,708,443...105,775,709
|
|
G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
multiple interactions affects binding |
EXP |
Ellagic Acid inhibits the reaction [TNFSF11 protein binds to TNFRSF11A protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of RELA protein] Ellagic Acid binds to TNFSF11 protein |
CTD |
PMID:32971123 |
|
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
|
|
G |
Tnnt2 |
troponin T2, cardiac |
multiple interactions |
ISO |
Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein] |
CTD |
PMID:21762681 |
|
NCBI chr 1:135,763,933...135,780,006
Ensembl chr 1:135,764,092...135,779,998
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression multiple interactions |
ISO |
Ellagic Acid results in increased expression of TP53 mRNA; Ellagic Acid results in increased expression of TP53 protein Ellagic Acid promotes the reaction [Quercetin results in increased phosphorylation of TP53 protein]; pifithrin inhibits the reaction [Ellagic Acid promotes the reaction [Quercetin results in increased phosphorylation of TP53 protein]] Ellagic Acid inhibits the reaction [phosalone results in increased expression of TP53 mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of TP53 protein] |
CTD |
PMID:15735102 PMID:23554011 PMID:27965107 PMID:35179410 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of UGP2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr11:21,271,126...21,321,267
Ensembl chr11:21,271,138...21,321,201
|
|
G |
Usp4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of USP4 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 9:108,223,763...108,269,744
Ensembl chr 9:108,225,052...108,269,744
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase1 |
increases expression |
ISO |
Ellagic Acid results in increased expression of WARS1 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr12:108,825,956...108,860,100
Ensembl chr12:108,825,956...108,860,100
|
|
G |
Wee1 |
WEE 1 homolog 1 (S. pombe) |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of WEE1 protein |
CTD |
PMID:23554011 |
|
NCBI chr 7:109,721,266...109,742,506
Ensembl chr 7:109,721,253...109,742,493
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
decreases expression |
ISO |
Ellagic Acid results in decreased expression of ZBTB16 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522
|
|
G |
Zmym2 |
zinc finger, MYM-type 2 |
increases expression |
ISO |
Ellagic Acid results in increased expression of ZMYM2 mRNA |
CTD |
PMID:12002526 |
|
NCBI chr14:57,123,986...57,199,815
Ensembl chr14:57,124,110...57,200,158
|
|